<abstract xmlns="http://www.w3.org/1999/xhtml"><p>A sample was submitted for serologic evaluation from a pregnant patient with immune thrombocytopenic purpura (ITP) for possible transfusion in the future because of a decreased platelet count. Anti-D and -E were identified in the patient’s serum using several antibody identification techniques, and anti-D was recovered in an acid eluate prepared from the patient’s red cells. It was discovered that WinRho™ had been administered to treat the ITP. This product has been licensed for treatment of nonsplenectomized D+ children and adults with ITP to increase the platelet count. Administration of anti-D to D+ individuals for treatment of ITP can cause a red cell anemia. <bold><italic>Immunohematology</italic> 1999;15:69–70</bold>.</p></abstract>

A sample was submitted for serologic evaluation from a pregnant patient with immune thrombocytopenic purpura (ITP) for possible transfusion in the future because of a decreased platelet count. Anti-D and -E were identified in the patient’s serum using several antibody identification techniques, and anti-D was recovered in an acid eluate prepared from the patient’s red cells. It was discovered that WinRho™ had been administered to treat the ITP. This product has been licensed for treatment of nonsplenectomized D+ children and adults with ITP to increase the platelet count. Administration of anti-D to D+ individuals for treatment of ITP can cause a red cell anemia. Immunohematology 1999;15:69–70.

Case report: passively acquired anti-D in a D+ pregnant patient

Immunohematology

{"article-title":"Case report: passively acquired anti-D in a D+ pregnant patient"}

A sample was submitted for serologic evaluation from a pregnant patient with immune thrombocytopenic purpura (ITP) for possible transfusion in the future...

Case report: passively acquired anti-D in a D+ pregnant patient

Publicado en línea: 26 oct 2020

Páginas: 69 - 70

DOI: https://doi.org/10.21307/immunohematology-2019-616

© 1999 M.P. Holub et al., published by Sciendo.